Last $31.98 USD
Change Today -0.75 / -2.29%
Volume 483.6K
SGEN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 06/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric L. Dobmeier J.D.

Chief Operating Officer, Seattle Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
43$2,190,160
As of Fiscal Year 2012

Background*

Mr. Eric L. Dobmeier, J.D. has been Chief Operating Officer of Seattle Genetics Inc., since June 17, 2011. Mr. Dobmeier served as the Chief Business Officer of Seattle Genetics Inc., from June 14, 2007 to June 17, 2011 and Corporate Secretary from 2002 to June 17, 2011. Mr. Dobmeier joined Seattle Genetics in March 2002 and manages its business development, legal, corporate communications, strategic marketing and project management groups. While at Seattle Genetics, ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

2012-Present
Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
Princeton University
JD
University of California-berkeley School of Law

Other Affiliations*

Annual Compensation*

Salary$440,463
Bonus$1,500
Total Annual Compensation$441,963

Stock Options*

Restricted Stock Awards$678,600
All Other Compensation$7,980
Exercised Options242,804
Exercised Options Value$3,091,031
Exercisable Options259,200
Exercisable Options Value$2,716,767
Unexercisable Options214,967
Unexercisable Options Value$1,272,861
Total Value of Options$7,080,659
Total Number of Options716,971

Total Compensation*

Total Annual Cash Compensation$693,071
Total Short Term Compensation$441,963
Other Long Term Compensation$686,580
Total Calculated Compensation$2,190,160
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $31.98 USD -0.75

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President and Executive Director
Cell Therapeutics, Inc.
$1.2M
Daniel M. Junius Chief Executive Officer, President and Director
ImmunoGen, Inc.
$480.0K
Cynthia L. Sullivan Chief Executive Officer, President, Director and President of IBC Pharmaceuticals Inc
Immunomedics Inc.
$580.6K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr9.4M
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$860.3K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.